Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
6.77
-0.05 (-0.73%)
At close: Jul 3, 2025, 1:00 PM
6.88
+0.11 (1.62%)
After-hours: Jul 3, 2025, 4:48 PM EDT
Jasper Therapeutics Market Cap
Jasper Therapeutics has a market cap or net worth of $101.70 million as of July 3, 2025. Its market cap has decreased by -72.28% in one year.
Market Cap
101.70M
Enterprise Value
55.49M
1-Year Change
-72.28%
Ranking
Category
Stock Price
$6.77
Market Cap Chart
Since January 10, 2020, Jasper Therapeutics's market cap has decreased from $122.75M to $101.70M, a decrease of -17.15%. That is a compound annual growth rate of -3.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 101.70M | -68.29% |
| Dec 31, 2024 | 320.73M | 264.33% |
| Dec 29, 2023 | 88.03M | 294.73% |
| Dec 30, 2022 | 22.30M | -94.26% |
| Dec 31, 2021 | 388.71M | 210.66% |
| Dec 31, 2020 | 125.13M | 1.93% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 306.47B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 238.56B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 216.08B |